Foundation artificial intelligence models for health recognition by use of face photographs (FAHR-Face): a model development and validation study
Background: Facial appearance offers a non-invasive window into health. We built Foundation Artificial Intelligence for Health Recognition-Face (FAHR-Face), a foundation model trained on more than 40 million facial photographs and fine-tuned it for two distinct tasks: biological age estimation (FAHR-FaceAge) and survival prediction (FAHR-FaceSurvival). Methods: FAHR-FaceAge underwent two-stage, age-balanced fine-tuning on ten public image datasets; FAHR-FaceSurvival was fine-tuned on 34 363 photographs of patien…

In brief
Researchers built a foundation model trained on over 40 million facial photographs and fine-tuned it into two tools: one that estimates biological age and one that predicts survival. The survival tool was tuned on 34,363 photographs of patients with cancer.
The work suggests that routine photographs could supply inexpensive risk information when conventional biomarkers are not available. The reported results come from model development and validation in cancer cohorts, so the source does not show whether using these tools changes patient care or outcomes.
Main points
- FAHR-FaceAge reached a mean absolute error of 5.1 years on public datasets and outperformed benchmark models.
- The highest-risk quartile from FAHR-FaceSurvival had more than triple the mortality of the lowest, with an adjusted hazard ratio of 3.23.
- Results were validated in an independent cancer cohort and across age, sex, race, and cancer subgroups.
- Attention mapping showed the two models relied on distinct facial regions, and combining them improved prognostic accuracy.
The gain
A face-photo AI model estimated age with a 5.1-year mean absolute error, and its survival model separated cancer patients by mortality risk, adding prognostic information.
The rundown
FAHR-FaceAge went through two-stage, age-balanced fine-tuning on ten public image datasets. It kept its accuracy across the full human lifespan and outperformed a previous age estimation model in survival prognostication among patients with cancer.
Robustness was tested against cosmetic surgery, make-up, pose, and lighting. Clinical testing used two independent cancer patient datasets, with survival analysed by multivariate Cox models adjusted for clinical prognostic factors.
The authors say the foundation approach allowed effective training from relatively small clinical datasets. They propose routine quantitative facial analysis as a way to improve risk stratification, and the work was funded by the EU European Research Council.
Sources
- Peer-reviewedThe Lancet Digital Health2027-06-16
ace
The debate